Alkem Laboratories Limited
ALKEM
Rang in Aktien
#2816
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aktienkurs
$55.19
Marktkapitalisierung
$6.60B
Veränderung (1 Tag)
-0.06%
Veränderung (1 Jahr)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategorie
Healthcare
Gewinn für Alkem Laboratories Limited (ALKEM)
Gewinn im Jun 2026 TTM: $316.88M
Laut den aktuellen Finanzberichten von Alkem Laboratories Limited betragen die aktuellen Gewinne des Unternehmens $316.88M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $242.63M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $158.77M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Alkem Laboratories Limited von 2010 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $316.88M | 7.25% |
| 2025 | $295.47M | 21.78% |
| 2024 | $242.63M | 52.82% |
| 2023 | $158.77M | -34.65% |
| 2022 | $242.96M | -3.45% |
| 2021 | $251.64M | 50.48% |
| 2020 | $167.23M | 21.64% |
| 2019 | $137.48M | -3.33% |
| 2018 | $142.22M | -4.39% |
| 2017 | $148.75M | 6.15% |
| 2016 | $140.14M | 93.97% |
| 2015 | $72.25M | -3.44% |
| 2014 | $74.83M | -20.27% |
| 2013 | $93.85M | 4.73% |
| 2012 | $89.61M | 12.42% |
| 2011 | $79.71M | 46.07% |
| 2010 | $54.57M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 456.85% |
IN
|
